[ad_1]
Samantha Ruth Prabhu has already started the promotions of Yashoda. The film is about a surrogacy scam. Now the actress is recovering from myositis, which is an autoimmune disease. Samantha Ruth Prabhu revealed how she lives with the disease, which is an inflammation of the muscles and joints. Samantha Ruth Prabhu has said that she is not going to die soon, contrary to what some reports claim. But she admitted that dealing with the disease was physically and emotionally draining. The actress was showered with words of encouragement from Bollywood and South Indian actors.
Promoting Yashoda in a black ensemble, Samantha Ruth Prabhu said she has good days and some bad days. She admitted that she has a hard time getting out of bed on certain days. Samantha said she wanted to fight the weakness of others. She said she took this platform to clarify that this is not a life-threatening condition. Samantha Ruth Prabhu said it is an autoimmune condition and she is determined to fight it. She said: “It’s exhausting and tiring. I have always been a fighter and I will fight.” Entertainment news is full of Samantha Ruth Prabhu and her myositis diagnosis.
The actress took three months off. Samantha Ruth Prabhu was supposed to start work on projects like Kushi and the web show with Raj and DK. She said she wanted to use her time off productively, but she didn’t. The actress was quoted as saying: “It was a dark time and very difficult. With high doses of medication and endless trips to doctors, my day was busy.” But she said it’s okay to fail some days. Samantha Ruth Prabhu said it’s okay to be vulnerable and sick and she doesn’t feel bad about it. Last year, she was in the news for her breakup with Naga Chaitanya. There were rumors that Nagarjuna and Naga Chaitanya had planned to visit her.
Stay tuned to BollywoodLife for the latest news and updates from Bollywood, Hollywood, South, TV and web series.
Click to join us on Facebook, TwitterYouTube and Instagram.
Also follow us on Facebook Messenger for the latest updates.
(function(d, s, id) { var js, fjs = d.getElementsByTagName(s)[0]; if (d.getElementById(id)) return; js = d.createElement(s); js.id = id; js.src="https://connect.facebook.net/en_US/sdk/xfbml.customerchat.js"; fjs.parentNode.insertBefore(js, fjs); }(document, 'script', 'facebook-jssdk'));
// jQuery(window).scroll(function(){ // if (isInView(jQuery('#live-blog-update'))){ // getMoreBlogEntries(); // } // });
$(document).ready(function(){ $('#commentbtn').on("click",function(){ (function(d, s, id) { var js, fjs = d.getElementsByTagName(s)[0]; if (d.getElementById(id)) return; js = d.createElement(s); js.id = id; js.src="https://connect.facebook.net/en_US/sdk.js#xfbml=1&version=v3.0&appId=179720252061082&autoLogAppEvents=1"; fjs.parentNode.insertBefore(js, fjs); }(document, 'script', 'facebook-jssdk'));
$(".cmntbox").toggle();
});
});
[ad_2]
Source link